Identification of somatic and psychosocial late and long-term effects and associated risk factors in long-term survivors of acute myeloid leukemia - a foundation for evidence-based follow up care

Identification of somatic and psychosocial late and long-term effects and associated risk factors in long-term survivors of acute myeloid leukemia - a foundation for evidence-based follow up care - AML CARE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035365

Enrollment

404

Registered

2025-05-28

Start date

2025-07-22

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0

Interventions

Group 1: AML long-term survivor cohort We will perform a cross-sectional questionnaire-based survey of medical and psycho-social late and long-term effects and collect medical data from recent follow-

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Persons who have been diagnosed with acute myeloid leukemia. Survival since the initial diagnosis of leukemia = 5 years

Exclusion criteria

Exclusion criteria: Current hematological relapse Lack of capacity to give informed consent Insufficient German language skills that impair the understanding of the written study materials or prevent independent completion of the questionnaire

Design outcomes

Primary

Measure	Time frame
Prevalence of long term and late effects measured by the functional comorbidity index	—

Secondary

Measure	Time frame
Anxiety and depression (HADS), quality of life and life satisfaction (EORTC-QLQ-SURV100, FLZ-M), fatigue (MFI), financial toxicity, work situation and return to work, information and support needs (custom questionnaires), social support (OSSS), prevalence of clonal hematopoiesis	—

Countries

Germany

Contacts

Public ContactKlaus Metzeler

Universitätsklinikum Leipzig

klaus.metzeler@medizin.uni-leipzig.de+49 341 97 13050

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026